Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GSAP mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSAP mRNA | CTD | PMID:22079256 | 17beta-estradiol | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Estradiol results in decreased expression of GSAP mRNA | CTD | PMID:25321415 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GSAP mRNA | CTD | PMID:32741896 | 17beta-estradiol | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of GSAP mRNA | CTD | PMID:30165855 | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GSAP mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GSAP mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GSAP mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Gsap (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSAP mRNA | CTD | PMID:26290441 | aflatoxin B1 | decreases methylation | ISO | GSAP (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of GSAP intron | CTD | PMID:30157460 | aflatoxin B1 | increases mutagenesis | EXP | | 6480464 | Aflatoxin B1 results in increased mutagenesis of GSAP gene | CTD | PMID:36908029 | all-trans-retinoic acid | increases expression | ISO | GSAP (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GSAP mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GSAP mRNA | CTD | PMID:15894607 | antirheumatic drug | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of GSAP mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of GSAP mRNA | CTD | PMID:33212167 | benzo[a]pyrene | affects methylation | ISO | GSAP (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GSAP 3' UTR and Benzo(a)pyrene affects the methylation of GSAP promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of GSAP mRNA | CTD | PMID:31163220 | bisphenol A | affects expression | ISO | GSAP (Homo sapiens) | 6480464 | bisphenol A affects the expression of GSAP mRNA | CTD | PMID:20170705 | bisphenol A | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of GSAP gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GSAP mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of GSAP gene | CTD | PMID:28505145 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GSAP mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GSAP mRNA | CTD | PMID:26063408 | butanal | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of GSAP mRNA | CTD | PMID:26079696 | carbon nanotube | affects expression | ISO | Gsap (Mus musculus) | 6480464 | Nanotubes and Carbon analog affects the expression of GSAP mRNA | CTD | PMID:25554681 | carbon nanotube | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | chloroprene | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | Chloroprene results in decreased expression of GSAP mRNA | CTD | PMID:23125180 | cisplatin | increases expression | ISO | GSAP (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GSAP mRNA | CTD | PMID:27594783 | cisplatin | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of GSAP mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of GSAP mRNA | CTD | PMID:19376846 | cyclosporin A | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GSAP mRNA | CTD | PMID:25562108 | cyclosporin A | increases expression | ISO | GSAP (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GSAP mRNA | CTD | PMID:27989131 | diallyl trisulfide | increases expression | ISO | GSAP (Homo sapiens) | 6480464 | diallyl trisulfide results in increased expression of GSAP mRNA | CTD | PMID:34995734 | dicrotophos | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of GSAP mRNA | CTD | PMID:28302478 | dioxygen | multiple interactions | ISO | Gsap (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSAP mRNA | CTD | PMID:30529165 | diquat | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | Diquat results in decreased expression of GSAP mRNA | CTD | PMID:36851058 | dorsomorphin | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of GSAP mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of GSAP mRNA | CTD | PMID:29391264 | ethanol | increases expression | ISO | Gsap (Mus musculus) | 6480464 | Ethanol results in increased expression of GSAP mRNA | CTD | PMID:30319688 | formaldehyde | increases expression | ISO | GSAP (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GSAP mRNA | CTD | PMID:23649840 | fulvestrant | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of GSAP gene | CTD | PMID:31601247 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of GSAP gene | CTD | PMID:22079235 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of GSAP mRNA | CTD | PMID:24136188 | leflunomide | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | leflunomide results in decreased expression of GSAP mRNA | CTD | PMID:28988120 | methylmercury chloride | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of GSAP mRNA | CTD | PMID:28001369 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of GSAP gene | CTD | PMID:33148267 | paracetamol | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of GSAP mRNA | CTD | PMID:21420995 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of GSAP gene | CTD | PMID:33148267 | phenobarbital | increases expression | ISO | Gsap (Mus musculus) | 6480464 | Phenobarbital results in increased expression of GSAP mRNA | CTD | PMID:19270015 | phenobarbital | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of GSAP mRNA | CTD | PMID:23091169 | pirinixic acid | multiple interactions | ISO | Gsap (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GSAP mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of GSAP mRNA | CTD | PMID:20813756 and PMID:23811191 | potassium chromate | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSAP mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of GSAP mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Gsap (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of GSAP mRNA | CTD | PMID:28903501 | resveratrol | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of GSAP mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of GSAP mRNA | CTD | PMID:19073995 | sodium arsenite | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of GSAP mRNA | CTD | PMID:36209798 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of GSAP mRNA | CTD | PMID:19281266 | succimer | multiple interactions | ISO | Gsap (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSAP mRNA | CTD | PMID:21641980 | sunitinib | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of GSAP mRNA | CTD | PMID:31533062 | testosterone | increases expression | ISO | GSAP (Homo sapiens) | 6480464 | Testosterone results in increased expression of GSAP mRNA | CTD | PMID:33359661 | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GSAP mRNA | CTD | PMID:32741896 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of GSAP mRNA | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of GSAP mRNA | CTD | PMID:31919559 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GSAP mRNA] | CTD | PMID:31150632 | tetraphene | increases expression | ISO | Gsap (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of GSAP mRNA | CTD | PMID:26377693 | trichostatin A | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of GSAP mRNA | CTD | PMID:24935251 | trichostatin A | increases expression | ISO | GSAP (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GSAP mRNA | CTD | PMID:24935251 | triptonide | decreases expression | ISO | Gsap (Mus musculus) | 6480464 | triptonide results in decreased expression of GSAP mRNA | CTD | PMID:33045310 | urethane | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Urethane results in decreased expression of GSAP mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | GSAP (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GSAP mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | GSAP (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GSAP mRNA | CTD | PMID:24935251 | valproic acid | decreases methylation | ISO | GSAP (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of GSAP gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GSAP mRNA | CTD | PMID:23179753 and PMID:26272509 | valproic acid | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSAP mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | GSAP (Homo sapiens) | 6480464 | vorinostat results in decreased expression of GSAP mRNA | CTD | PMID:26272509 | vorinostat | multiple interactions | ISO | GSAP (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSAP mRNA | CTD | PMID:27188386 | |